These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 19047288)

  • 1. Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international Phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups.
    Slotman BJ; Mauer ME; Bottomley A; Faivre-Finn C; Kramer GW; Rankin EM; Snee M; Hatton M; Postmus PE; Collette L; Senan S
    J Clin Oncol; 2009 Jan; 27(1):78-84. PubMed ID: 19047288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01).
    Le Péchoux C; Laplanche A; Faivre-Finn C; Ciuleanu T; Wanders R; Lerouge D; Keus R; Hatton M; Videtic GM; Senan S; Wolfson A; Jones R; Arriagada R; Quoix E; Dunant A;
    Ann Oncol; 2011 May; 22(5):1154-1163. PubMed ID: 21139020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life after prophylactic cranial irradiation for stage III non-small cell lung cancer patients: Results from the NVALT-11/DLCRG-02 phase III study.
    Witlox WJA; Ramaekers BLT; Joore MA; Dingemans AC; Praag J; Belderbos J; Tissing-Tan C; Herder G; Haitjema T; Ubbels JF; Lagerwaard J; El Sharouni SY; Stigt JA; Smit EF; van Tinteren H; van der Noort V; Groen HJM; De Ruysscher DKM
    Radiother Oncol; 2020 Mar; 144():65-71. PubMed ID: 31733490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Early Prophylactic Cranial Irradiation With Hippocampal Avoidance on Neurocognitive Function in Patients With Limited Disease Small Cell Lung Cancer. A Multicenter Phase 2 Trial (SAKK 15/12).
    Vees H; Caparrotti F; Eboulet EI; Xyrafas A; Fuhrer A; Meier U; Mark M; Elicin O; Aebersold DM; Zwahlen DR; Finazzi T; Allal AS; Putora PM; Martucci F; Rudolf CB; Ribi K;
    Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):279-287. PubMed ID: 32142869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment Design and Rationale for a Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for SCLC: PREMER Trial on Behalf of the Oncologic Group for the Study of Lung Cancer/Spanish Radiation Oncology Group-Radiation Oncology Clinical Research Group.
    Rodríguez de Dios N; Couñago F; López JL; Calvo P; Murcia M; Rico M; Vallejo C; Luna J; Trueba I; Cigarral C; Farre N; Manero RM; Durán X; Samper P
    Clin Lung Cancer; 2018 Sep; 19(5):e693-e697. PubMed ID: 29891263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results.
    Soffietti R; Kocher M; Abacioglu UM; Villa S; Fauchon F; Baumert BG; Fariselli L; Tzuk-Shina T; Kortmann RD; Carrie C; Ben Hassel M; Kouri M; Valeinis E; van den Berge D; Mueller RP; Tridello G; Collette L; Bottomley A
    J Clin Oncol; 2013 Jan; 31(1):65-72. PubMed ID: 23213105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis.
    Sun A; Bae K; Gore EM; Movsas B; Wong SJ; Meyers CA; Bonner JA; Schild SE; Gaspar LE; Bogart JA; Werner-Wasik M; Choy H
    J Clin Oncol; 2011 Jan; 29(3):279-86. PubMed ID: 21135267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal Brain Changes Associated with Prophylactic Cranial Irradiation in Lung Cancer.
    Simó M; Vaquero L; Ripollés P; Gurtubay-Antolin A; Jové J; Navarro A; Cardenal F; Bruna J; Rodríguez-Fornells A
    J Thorac Oncol; 2016 Apr; 11(4):475-86. PubMed ID: 26804637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study.
    Rodríguez de Dios N; Couñago F; Murcia-Mejía M; Rico-Oses M; Calvo-Crespo P; Samper P; Vallejo C; Luna J; Trueba I; Sotoca A; Cigarral C; Farré N; Manero RM; Durán X; Gispert JD; Sánchez-Benavides G; Rognoni T; Torrente M; Capellades J; Jiménez M; Cabada T; Blanco M; Alonso A; Martínez-San Millán J; Escribano J; González B; López-Guerra JL
    J Clin Oncol; 2021 Oct; 39(28):3118-3127. PubMed ID: 34379442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic cranial irradiation in extensive disease small cell lung cancer: An endless debate.
    Picardi C; Caparroti F; Di Maio M; Kaššák F; Banna GL; Addeo A
    Crit Rev Oncol Hematol; 2019 Nov; 143():95-101. PubMed ID: 31563079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Patterns of Care for Patients with Extensive-Stage SCLC: Survey of U.S. Radiation Oncologists on Their Recommendations Regarding Prophylactic Cranial Irradiation.
    Jain A; Luo J; Chen Y; Henderson MA; Thomas CR; Mitin T
    J Thorac Oncol; 2016 Aug; 11(8):1305-1310. PubMed ID: 27237826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214.
    Gondi V; Paulus R; Bruner DW; Meyers CA; Gore EM; Wolfson A; Werner-Wasik M; Sun AY; Choy H; Movsas B
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):656-64. PubMed ID: 23597420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic Cranial Irradiation Versus Observation in Radically Treated Stage III Non-Small-Cell Lung Cancer: A Randomized Phase III NVALT-11/DLCRG-02 Study.
    De Ruysscher D; Dingemans AC; Praag J; Belderbos J; Tissing-Tan C; Herder J; Haitjema T; Ubbels F; Lagerwaard F; El Sharouni SY; Stigt JA; Smit E; van Tinteren H; van der Noort V; Groen HJM
    J Clin Oncol; 2018 Aug; 36(23):2366-2377. PubMed ID: 29787357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk stratification of symptomatic brain metastases by clinical and FDG PET parameters for selective use of prophylactic cranial irradiation in patients with extensive disease of small cell lung cancer.
    Chung JH; Kang SY; Wu HG; Seo YS; Kim DW; Kang KW; Kim HJ; Cheon GJ
    Radiother Oncol; 2020 Feb; 143():81-87. PubMed ID: 32044172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive Interaction between Prophylactic Cranial Irradiation and Maintenance Sunitinib for Untreated Extensive-Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis of CALGB 30504 (ALLIANCE).
    Salama JK; Gu L; Wang X; Pang HH; Bogart JA; Crawford J; Schild SE; Vokes EE; Ready NE
    J Thorac Oncol; 2016 Mar; 11(3):361-9. PubMed ID: 26723241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer.
    Wolfson AH; Bae K; Komaki R; Meyers C; Movsas B; Le Pechoux C; Werner-Wasik M; Videtic GM; Garces YI; Choy H
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):77-84. PubMed ID: 20800380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic Cranial Irradiation in Patients With High-Risk Metastatic Non-Small Cell Lung Cancer: Quality of Life and Neurocognitive Analysis of a Randomized Phase II Study.
    Maldonado F; Gonzalez-Ling A; Oñate-Ocaña LF; Cabrera-Miranda LA; Zatarain-Barrón ZL; Turcott JG; Flores-Estrada D; Lozano-Ruiz F; Cacho-Díaz B; Arrieta O
    Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):81-92. PubMed ID: 33915217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
    Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
    Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase 3 Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC (NCT01780675).
    Belderbos JSA; De Ruysscher DKM; De Jaeger K; Koppe F; Lambrecht MLF; Lievens YN; Dieleman EMT; Jaspers JPM; Van Meerbeeck JP; Ubbels F; Kwint MH; Kuenen MA; Deprez S; De Ruiter MB; Boogerd W; Sikorska K; Van Tinteren H; Schagen SB
    J Thorac Oncol; 2021 May; 16(5):840-849. PubMed ID: 33545387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does surgically resected small-cell lung cancer without lymph node involvement benefit from prophylactic cranial irradiation?
    Lou Y; Zhong R; Xu J; Qiao R; Teng J; Zhang Y; Zhang X; Chu T; Zhong H; Han B
    Thorac Cancer; 2020 May; 11(5):1239-1244. PubMed ID: 32142599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.